Interferon-gamma increases the ratio of matrix metalloproteinase-9/tissue inhibitor of metalloproteinase-1 in peripheral monocytes from patients with coronary artery disease - Wikidata - awgldk - TriplyDB

Interferon-gamma increases the ratio of matrix metalloproteinase-9/tissue inhibitor of metalloproteinase-1 in peripheral monocytes from patients with coronary artery disease

Interferon-gamma increases the ratio of matrix metalloproteinase-9/tissue inhibitor of metalloproteinase-1 in peripheral monocytes from patients with coronary artery disease

http://www.wikidata.org/entity/Q34951441

about

Much More than M1 and M2 Macrophages, There are also CD169(+) and TCR(+) Macrophages.Interferon-gamma Genetic Polymorphism and Expression in Kawasaki Disease.Plasma cytokines and risk of coronary heart disease in the PROCARDIS study.

P2860

Q35646486-221CEBE5-EC34-4DAA-A0C0-7E9820A7F3A5 Q37206453-6FEB58AE-4DB1-4013-90DE-95FE7A2EED08 Q55395813-6874B7E2-C16F-4363-B252-90F45C7BE690

P2860

Interferon-gamma increases the ratio of matrix metalloproteinase-9/tissue inhibitor of metalloproteinase-1 in peripheral monocytes from patients with coronary artery disease

http://www.wikidata.org/entity/Q34951441

description

2013 nî lūn-bûn

@nan

2013 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Interferon-gamma increases the ...... s with coronary artery disease

@ast

Interferon-gamma increases the ...... s with coronary artery disease

@en

Interferon-gamma increases the ...... s with coronary artery disease

@nl

type

label

Interferon-gamma increases the ...... s with coronary artery disease

@ast

Interferon-gamma increases the ...... s with coronary artery disease

@en

Interferon-gamma increases the ...... s with coronary artery disease

@nl

prefLabel

Interferon-gamma increases the ...... s with coronary artery disease

@ast

Interferon-gamma increases the ...... s with coronary artery disease

@en

Interferon-gamma increases the ...... s with coronary artery disease

@nl

P1433

Q34951441-F4380709-AF09-48F2-9DEA-43D8187ED32A

P1476

Q34951441-E0A108F2-D921-40B0-93B0-73365BC60B25

P2093

Q34951441-0E5E5DC3-9CAE-459C-BC35-2B5F4443FDFB

Q34951441-206D1282-2E1F-4B18-9D7E-34BCCC822064

Q34951441-2409893F-BC1F-460E-B2A5-CD9E960FA4C9

Q34951441-37813710-63F7-47FF-829F-BCE23F267582

Q34951441-56EE6D52-6FC5-4997-940C-9C6228C46A13

Q34951441-93A6D60D-6143-4EE3-9D08-E83F0B81DA6A

Q34951441-C0372575-CDD4-4514-91C0-543520BF632A

Q34951441-C61919FC-DA35-43C4-A069-B0347BADA025

Q34951441-E33824BE-49E1-4B48-8468-3413085C5C41

Q34951441-E3C7DC9B-1FD0-4A1E-A420-5DF0C7FAC127

P2860

Q34951441-005144FA-61A5-4234-9A97-E8BDF52D1536

Q34951441-135D0CAB-E8FB-4627-8A2C-2BAA75B926F2

Q34951441-1F81DCD9-937E-484B-961E-BBA69D35790B

Q34951441-25134F44-F2D4-40EB-AEB7-48205D6C0700

Q34951441-2F92BC6D-168F-4663-ACDE-7EF80AE3CF9D

Q34951441-34E5222E-F171-455A-A8C8-D190E1496954

Q34951441-36C6073E-5136-40CB-BA46-7C0FB7FAE987

Q34951441-49771A46-4DA5-430C-8B50-37937BEED9FB

Q34951441-638CCE6B-E499-43C3-A888-FF7A63E77F5A

Q34951441-69F317C2-D0E5-483D-9322-8FB780E5229E

P304

Q34951441-69184F80-46D9-4AC1-8834-0398BBFF4B98

P31

Q34951441-DAE93C10-0D3F-4F9B-867A-48208AD166DF

P356

Q34951441-17D719E6-79D2-4512-BAE2-BD2D98F8BF8A

P407

Q34951441-02ECF5AA-A3E6-4542-90D3-F603767211A8

P433

Q34951441-D8D09632-3E97-4126-9BDF-C08ED3BA43F4

P478

Q34951441-775BFA4D-D6BF-4046-9482-51DE950ED431

P577

Q34951441-7890F3FB-AAA0-4338-A573-F1CBCCDD8824

P5875

Q34951441-877994D7-C5AC-4412-8C56-0D36955A8FB8

P698

Q34951441-4211B449-15AF-4F22-B57D-A836FC5B9F93

P932

Q34951441-E1041027-2845-4831-B977-D640B1A81851

P356

JOURNAL.PONE.0072291

P1433

P1476

Interferon-gamma increases the ...... s with coronary artery disease

@en

P2093

Ana María Mejía-Domínguez

http://www.w3.org/2001/XMLSchema#string

Carlos Martínez-Sánchez

http://www.w3.org/2001/XMLSchema#string

Hector Gonzalez-Pacheco

http://www.w3.org/2001/XMLSchema#string

Janette Furuzawa-Carballeda

http://www.w3.org/2001/XMLSchema#string

Jorge Cossío-Aranda

http://www.w3.org/2001/XMLSchema#string

Lorena Gomez-Garcia

http://www.w3.org/2001/XMLSchema#string

Luis M Amezcua-Guerra

http://www.w3.org/2001/XMLSchema#string

Rafael Bojalil

http://www.w3.org/2001/XMLSchema#string

Rashidi Springall

http://www.w3.org/2001/XMLSchema#string

Ricardo Marquez-Velasco

http://www.w3.org/2001/XMLSchema#string

P2860

American College of Cardiology key data elements and definitions for measuring the clinical management and outcomes of patients with acute coronary syndromes. A report of the American College of Cardiology Task Force on Clinical Data Standards (Acut

Interferon gamma: a master regulator of atherosclerosis.

Plaque pathology and coronary thrombosis in the pathogenesis of acute coronary syndromes.

Plasma tissue inhibitor of metalloproteinase-1 and matrix metalloproteinase-9: novel indicators of left ventricular remodelling and prognosis after acute myocardial infarction.

Clinical characteristics, process of care and outcomes among Mexican, Hispanic and non-Hispanic white patients presenting with non-ST elevation acute coronary syndromes: data from RENASICA and CRUSADE registries.

Immune modulation of metalloproteinase production in human macrophages. Selective pretranslational suppression of interstitial collagenase and stromelysin biosynthesis by interferon-gamma.

Circulating influenza virus, climatic factors, and acute myocardial infarction: a time series study in England and Wales and Hong Kong.

Influenza infection and risk of acute myocardial infarction in England and Wales: a CALIBER self-controlled case series study.

Plasma matrix metalloproteinase-9 and left ventricular remodelling after acute myocardial infarction in man: a prospective cohort study

Relationships of adiponectin and matrix metalloproteinase-9 to tissue inhibitor of metalloproteinase-1 ratio with coronary plaque morphology in patients with acute coronary syndrome.

P304

e72291

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0072291

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2013-08-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

255959936

http://www.w3.org/2001/XMLSchema#string

P698

23951304

http://www.w3.org/2001/XMLSchema#string

P932

3741271

http://www.w3.org/2001/XMLSchema#string